Semax
Synthetic heptapeptide analog of ACTH(4-7) with C-terminal Pro-Gly-Pro modification. Neuroprotective and nootropic peptide developed in Russia. Plasma half-life ~20-30 min but functional neurological effects persist for hours. Administered intranasally. Enhances BDNF expression and modulates serotonergic/dopaminergic systems.
Projected serum levels — 600 mcg (≈ 0.60 mg), once daily
Maintenance schedule: 600 mcg (≈ 0.60 mg) once daily (insufflated).
Modeled steady state after ~1 days: peak ≈ 0.17 mg, trough ≈ 0.000 mg body load. Population-based estimate over 15 days for a reference dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.
Key facts
- Category
- Peptide
- Route modeled
- Insufflated
- Model confidence
- inferred
- Half-life
- 22 min
- Common dose
- 600 mcg (≈ 0.60 mg)
- Suggested maximum
- 1.8k mcg/day
- Reference dose range
- 300–1.8k mcg (single dose)
- Suggested cadence
- once daily
Documented interactions
-
watch
Lion's Mane (Hericium erinaceus) + Semax
Lion's Mane (Hericium erinaceus) and Semax both push the nerve growth factor pathway in the same direction.
-
watch
Melanotan II + Semax
Melanotan II and Semax both push the mc4r in the same direction.
-
watch
Noopept (GVS-111 / Omberacetam) + Semax
Noopept (GVS-111 / Omberacetam) and Semax both push the bdnf signaling in the same direction.
-
watch
PQQ (Pyrroloquinoline Quinone) + Semax
PQQ (Pyrroloquinoline Quinone) and Semax both push the nerve growth factor pathway in the same direction.
-
watch
PT-141 (Bremelanotide) + Semax
PT-141 (Bremelanotide) and Semax both push the mc4r in the same direction.
-
watch
Selank + Semax
Selank and Semax both push the bdnf signaling in the same direction.
Serum checks 7 modeled interaction pairings for semax across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.
Research behind this entry
-
Selank and Semax modulate the activity of neurotransmitter systems
Demonstrated that Semax modulates dopaminergic and serotonergic neurotransmitter systems in rat brain, supporting its nootropic and neuroprotective mechanisms of action.
-
Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats
Transcriptomic analysis revealing Semax modulates expression of 70+ genes involved in inflammation, apoptosis, and neurotransmission following ischemic brain injury in rats.
-
The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia
Microarray study showing Semax treatment after focal ischemia suppresses pro-inflammatory gene expression while activating genes involved in neurovascular repair.
-
Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.
This citation reports an animal study involving Semax. It does not by itself establish a qualified dose, safety profile, efficacy claim, or pharmacokinetic route for this record.
4 published studies referenced in the app, each with a plain-language summary.